Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.
Securing comparator drugs in the EU is a complex process shaped by availability constraints, regulatory expectations, and competitive market behavior. But if we have the right planning, strong ...
People with Parkinson's disease and Lewy body dementia have increased rates of incident depression from seven to eight years ...
In today’s ACT Brief, we examine the growing challenges of sourcing comparator drugs across the EU, highlight a new AI-driven ...
The U.S. Supreme Court agreed to hear a closely watched retirement plan lawsuit against Intel Corp., taking up a case that ...
An Alabama federal district court granted the Monroe County Board of Education and its superintendent’s motion for summary judgment, dismissing a Black female director of student services’ Title VII ...
Document fraud often involves altering legitimate documents or misusing blank originals. Hyperspectral analysis allows forensic experts to examine inks and colors at the pixel level and assess their ...
Polyrizon Ltd. Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions today announced positive results from ...
The results build on evidence U.S. regulators found so compelling last year they proactively awarded J&J a new kind of drug ...
The regulator’s Office of Prescription Drug Promotion (OPDP) has already sent out two letters alleging “false or misleading” ...
Patients with autoimmune hepatitis have no increased long-term risk for psychiatric disorders compared with the general population.
IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback